A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis.
Open Access
- 1 November 1983
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 67 (11) , 746-750
- https://doi.org/10.1136/bjo.67.11.746
Abstract
Topical acyclovir has been compared with topical steroids in a coded controlled trial of the treatment of keratouveitis caused by herpes zoster in 40 patients. Topical acyclovir was significantly superior to topical steroids in terms of treatment duration (75 days to 280 days), with no recurrences after the patients were weaned off treatment; there was a 63% recurrence rate in the steroid group. Corneal epithelial disease resolved significantly quicker in the acyclovir treated group. If recurrences occurred in the steroid group, other parts of the eye not initially affected were also involved. Treatment of such recurrences was more difficult than treatment of the initial attack.This publication has 17 references indexed in Scilit:
- Complications of Herpes Zoster OphthalmicusArchives of Ophthalmology (1950), 1983
- ACYCLOVIR THERAPY FOR ACUTE HERPES ZOSTERThe Lancet, 1982
- ACYCLOVIR IN HERPES ZOSTERThe Lancet, 1981
- Topical acyclovir in herpes zoster ocular involvement.British Journal of Ophthalmology, 1981
- Pathogenesis of Varicella-Zoster Angiitis in the CNSArchives of Neurology, 1980
- Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with CancerNew England Journal of Medicine, 1978
- Herpetic Corneal Epithelial DiseaseArchives of Ophthalmology (1950), 1976
- Herpes Zoster Ophthalmicus and Delayed Contralateral HemiparesisJAMA, 1974
- Herpes Zoster Dendritic KeratitisArchives of Ophthalmology (1950), 1973
- Interferon, antibody, and other host factors in herpes zosterJournal of Clinical Investigation, 1972